Pentixapharm Holding AG (ETR:PTP)
Germany · Delayed Price · Currency is EUR 1.740
+0.015 (0.87%)
Oct 26, 2026, 5:35 PM CET
Pentixapharm Holding AG Revenue
Pentixapharm Holding AG had revenue of 15.00K EUR in the quarter ending June 30, 2026, a decrease of -91.18%. This brings the company's total for the last twelve months to 242.00K, down -86.48% year-over-year. In the year 2025, Pentixapharm Holding AG had annual revenue of 526.00K, down -63.28%. That makes Pentixapharm Holding AG the 45,197th largest company in the world by revenue and 618th in Germany.
Revenue (ttm)
242.00K
Revenue Growth
-86.48%
P/S Ratio
178.19
Revenue / Employee
6.37K
Employees
38
Market Cap
43.12M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 526.00K | -906.50K | -63.28% |
| Jan 1, 2025 | 1.43M | -331.50K | -18.79% |
| Dec 31, 2023 | 1.76M | 1.73M | 5,590.32% |
| Dec 31, 2022 | 31.00K | -30.00K | -49.18% |
| Dec 31, 2021 | 61.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.38B |
| Fresenius SE & Co. KGaA | 23.28B |
| Siemens Healthineers AG | 23.17B |
| Merck KGaA | 21.14B |
| Maternus-Kliniken Aktiengesellschaft | 119.35M |
| FamiCord AG | 87.78M |
| DocCheck AG | 56.65M |
| MeVis Medical Solutions AG | 15.48M |